Isocaloric maternal low-protein diet alters IGF-I, IGFBPs, and hepatocyte proliferation in the fetal rat

Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E991-E1000. doi: 10.1152/ajpendo.00037.2003. Epub 2003 Aug 5.

Abstract

We investigated the effect of an isocaloric maternal low-protein diet during pregnancy in rats on the proliferative capacity of cultured fetal hepatocytes. The potential roles of these changes on the IGF-IGF-binding protein (IGFBP) axis, and the role of insulin and glucocorticoids in liver growth retardation, were also evaluated. Pregnant Wistar rats were fed a control (C) diet (20% protein) or a low-protein (LP) diet (8%) throughout gestation. In primary culture, the DNA synthesis of hepatocytes derived from LP fetuses was decreased by approximately 30% compared with control hepatocytes (P < 0.05). In parallel, in vivo moderate protein restriction in the dam reduced the fetal liver weight and IGF-I level in fetal plasma (P < 0.01) and augmented the abundance of 29- to 32-kDa IGFBPs in fetal plasma (P < 0.01) and fetal liver (P < 0.01). By contrast, the abundance of IGF-II mRNA in liver of LP fetuses was unaffected by the LP diet. In vitro, the LP-derived hepatocytes produced less IGF-I (P < 0.01) and more 29- to 32-kDa IGFBPs (P < 0.01) than hepatocytes derived from control fetuses. These alterations still appeared after 3-4 days of culture, indicating some persistence in programming. Dexamethasone treatment of control-derived hepatocytes decreased cell proliferation (54 +/- 2.3%, P < 0.01) and stimulated 29- to 32-kDa IGFBPs, whereas insulin promoted fetal hepatocyte growth (127 +/- 5.5%, P < 0.01) and inhibited 29- to 32-kDa IGFBPs. These results show that liver growth and cell proliferation in association with IGF-I and IGFBP levels are affected in utero by fetal undernutrition. It also suggests that glucocorticoids and insulin may modulate these effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Division*
  • Cells, Cultured
  • Dexamethasone / pharmacology
  • Diet, Protein-Restricted*
  • Female
  • Fetal Blood / chemistry
  • Fetus*
  • Glucocorticoids / pharmacology
  • Hepatocytes / cytology
  • Humans
  • Immunoenzyme Techniques
  • Insulin / pharmacology
  • Insulin-Like Growth Factor Binding Protein 1 / analysis
  • Insulin-Like Growth Factor Binding Protein 1 / pharmacology
  • Insulin-Like Growth Factor Binding Protein 2 / analysis
  • Insulin-Like Growth Factor Binding Proteins / analysis*
  • Insulin-Like Growth Factor Binding Proteins / blood
  • Insulin-Like Growth Factor I / analysis*
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor II / genetics
  • Liver / chemistry
  • Liver / cytology
  • Liver / embryology*
  • Maternal-Fetal Exchange
  • Organ Size
  • Pregnancy
  • RNA, Messenger / analysis
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / pharmacology

Substances

  • Glucocorticoids
  • Insulin
  • Insulin-Like Growth Factor Binding Protein 1
  • Insulin-Like Growth Factor Binding Protein 2
  • Insulin-Like Growth Factor Binding Proteins
  • RNA, Messenger
  • Recombinant Proteins
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Dexamethasone